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Iowa City, IowaFIGURE 1. The intra-aortic balloon pump is inserted through a 6-mmIntra-aortic counterpulsation therapy is unanimously recog-
nized as a fundamental tool to support patients with cardiac
failure in the preoperative and postoperative periods. The
intra-aortic balloon pump (IABP) is routinely inserted
through the femoral artery, but in many circumstances this
option is not available in patients with occlusive peripheral
vascular disease. Access through the upper extremities rep-
resents a possible alternative but is often cumbersome and
exposed to a high incidence of complications.
We present a technique of intraoperative insertion of the
IABP through the innominate artery using a Dacron graft
conduit tunneled to the skin above or below the right
clavicle.
CLINICAL SUMMARY
The IABP is inserted through a 6-mm Dacron graft sewn
to the sidewall of the innominate artery and ultimately
tunneled through the soft tissue behind the manubrium.
The graft is sewn end-to-side to the takeoff of the innominate
artery by using a side-biting clamp. The graft is tunneled be-
hind the manubrium and exited at the skin above or below
the right clavicle (Figure 1). The Dacron graft is ligated dis-
tally, and the IABP sheath is inserted into the sidewall of the
Dacron graft and secured (Figure 2). The IABP can be ma-
nipulated and advanced through the innominate artery into
the aortic arch. Appropriate positioning in the descending
thoracic aorta is completed under transesophageal echocar-
diographic guidance. The sternotomy is closed, and the
IABP insertion site is covered with sterile dressing. Once
the patient can be weaned off counterpulsation therapy, the
IABP is withdrawn at the bedside. The Dacron graft is li-
gated and shortened under sterile conditions and ultimately
harbored into the skin incision, which can be closed after
achievement of local anesthesia.
We used this technique in 2 patients. Both had occlusive
iliacofemoral disease, which prevented preoperative com-
pletion of coronary artery catheterization from the femoral
arteries. Both patients required counterpulsation therapy to
Dacron graft sewn to the innominate artery and tunneled to the skin behind
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586 The Journal of Thoracic and Cardiovascular Surgsuccessfully be weaned off cardiopulmonary bypass. One
patient died on postoperative day 3 from multiorgan failure
caused by low cardiac output state but did not have compli-
cations related to the IABP. The second patient had the
IABP removed at the bedside on postoperative day 2. He
was extubated successfully and transferred to the floor onery c February 2011
FIGURE 2. Intraoperative image.
Brief Technique Reportspostoperative day 4. No complications related to the IABP
were encountered.DISCUSSION
The IABP acts by increasing diastolic pressure, reducing
afterload, increasing coronary artery perfusion, and ulti-
mately increasing stroke volume and cardiac output, with
reduction of myocardial oxygen demand. Since its clinical
introduction in the early 1970s, the use of intra-aortic coun-
terpulsation therapy in the perioperative period has been
shown to decrease mortality in patients with severely
decreased ventricular function undergoing cardiac sur-
gery.1,2 Intraoperative placement of an IABP might facili-
tate discontinuation of cardiopulmonary bypass and
stabilization of the hemodynamics in patients with poor ven-
tricular function and long pump times.3 A technique similar
to the one we describe for insertion directly into the aorta of
a balloon designed for cannulation into the femoral arteries
was described in 1983 by Salerno,4 in which the Dacron
graft is sewn to the ascending aorta and tunneled behind
the sternum below the xyphoid process. Other authors
described a similar technique in which the IABP is passed
directly through the sternotomy incision.5 The advantageThe Journal of Thoracic and Caof our technique stands in the fact that it might be techni-
cally easier and safer to sew the Dacron graft to the innom-
inate artery compared with the ascending aorta already
crowded with coronary artery bypass grafts, arterial perfu-
sion, and deairing cannulas. The IABP can be manipulated
and guided by means of palpation into the aortic arch. Ap-
propriate positioning in the descending thoracic aorta can be
obtained under transesophageal echocardiographic guid-
ance. Alternatively, epiaortic ultrasound can be used to
guide the insertion maneuver.
Another advantage is that the Dacron graft runs for a short
distance behind the manubrium and does not pass through or
behind the sternotomy, as described by other authors. This
might result in a decreased risk of deep sternal wound infec-
tions. Furthermore, the use of a sheathed balloon introduced
through the sidewall of the Dacron graft makes balloon re-
moval easy and safe at the bedside. We acknowledge that
this technique might increase the risk of life-threatening
complications, such as dissection of the innominate artery,
bleeding at the anastomosis site, and brain embolization.
In addition, there is increased risk of mediastinal contamina-
tion and sternal wound infection. However, we believe that
in extreme circumstances in patients with occlusive periph-
eral vascular disease, it can represent an indispensable tool
for discontinuation of cardiopulmonary bypass in the operat-
ing room and support of compromised patients in the imme-
diate postoperative period.References
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